There are only two time point measures in the EXCELLENCE trial just as in the two previous trials.
A linear mixed model is as meaningless as AUC with just to samples versus REPEATED time points, but sounds amazing science and statistics to those biotech ‘investor’ with little to no clue.
Any number of times quoting from a PR is not equal to better understanding, but the opposite.
Market Data 
Markets 
AI
